Acurx Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACXP Nasdaq 2830 www.acurxpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - May 12th, 2026 11:05 am
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update - May 12th, 2026 5:01 am
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026 - May 4th, 2026 6:00 am
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - Apr 29th, 2026 6:00 am
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit - Apr 27th, 2026 6:00 am
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update - Apr 20th, 2026 6:00 am
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS) - Apr 18th, 2026 8:00 am
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Apr 16th, 2026 2:01 pm
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Apr 16th, 2026 6:00 am
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Apr 11th, 2026 7:35 am
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events - Apr 7th, 2026 7:00 am
New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST) - Apr 4th, 2026 8:05 am
Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year? - Apr 2nd, 2026 7:40 am
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors - Mar 30th, 2026 5:01 am
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX) - Mar 28th, 2026 9:00 am
Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ... - Mar 23rd, 2026 7:00 pm
Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - Mar 19th, 2026 7:55 am
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? - Mar 17th, 2026 7:40 am
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update - Mar 13th, 2026 5:01 am
BC-Most Active Stocks - Mar 11th, 2026 8:30 am